Weight Off-loading Training, Cardiovascular Indices, Diabetes
Efficacy of Aerobic Training Using Lower Body Positive Pressure Technology on Cardiovascular Disease Risk and Peripheral Vascular Health in Patients With Type 2 Diabetes Mellitus. Randomized Controlled Study
1 other identifier
interventional
46
1 country
1
Brief Summary
Aims: To evaluate the effectiveness of partial weight-bearing during aerobic exercise training on cardiovascular disease risk and peripheral vascular function in patients with type 2 diabetes mellitus. Study design: A Randomized controlled study was conducted in the outpatient rehabilitation unit. Population: Forty-six participants (age 60 -70) with type 2 diabetes mellitus were recruited and randomly allocated into three groups: group A (100% weight-bearing; n=16), group B (75% weight-bearing; n=16), and group C (control group; n=14). Methods: The 2 study groups A and B, received three sessions per week of moderate intensity (60-75% heart rate reserve) aerobic exercise training, for 12 weeks, 50-60 minutes session duration (including warm-up and cool-down), on the antigravity treadmill. The cardiovascular disease risk (evaluated using the Atherosclerotic cardiovascular disease risk estimator plus tool) and peripheral vascular function (presented by ankle-brachial pressure index, calculated by subdividing the ankle systolic blood pressure by the brachial systolic blood pressure) are the main study outcomes. Variables were evaluated pre-study and post-study. Ethical concepts and institutional regulations were adhered during the study. Data were described as mean and standard deviation. Paired samples t-test and one-way ANOVA were used to test within and between-subjects assumptions, respectively, considering p\< 0.05 as the significance level.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2025
CompletedFirst Submitted
Initial submission to the registry
May 7, 2025
CompletedFirst Posted
Study publicly available on registry
May 15, 2025
CompletedMay 15, 2025
May 1, 2025
7 months
May 7, 2025
May 7, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in the cardiovascular disease risk at 12-week.
The cardiovascular disease risk was evaluated using the Atherosclerotic cardiovascular disease risk estimator plus tool, and was evaluated pre-study and at 12 weeks (end of the study).
From enrollment to the end of treatment at 12 weeks.
Change in the peripheral vascular function at 12-week.
The peripheral vascular function (presented by ankle-brachial pressure index) was calculated by dividing the ankle systolic blood pressure by the brachial systolic blood pressure, and was evaluated pre-study and at 12 weeks (end of the study).
From enrollment to the end of treatment at 12 weeks.
Study Arms (3)
Experimental Group-1 (group-A; 0% weight off-loading)
ACTIVE COMPARATORThis group (100% weight-bearing group) received three sessions per week of moderate-intensity (60-75% heart rate reserve) aerobic exercise training, for 12 weeks, 50-60 minutes' session duration (including warm-up and cool-down), on the antigravity treadmill. Participants also received regular oral anti-diabetic medications.
Experimental Group-2 (group-B; 25% weight off-loading)
EXPERIMENTALThis group (27% weight-bearing group) received three sessions per week of moderate-intensity (60-75% heart rate reserve) aerobic exercise training, for 12 weeks, 50-60 minutes' session duration (including warm-up and cool-down), on the antigravity treadmill. Participants also received regular oral anti-diabetic medications.
Control group (Group; Non-exercising group)
OTHERThe control group participants received the same pre- and post-study evaluations as those for the study groups A and B, but did not participate in any aerobic exercise training on the antigravity treadmill. Participants only received regular oral anti-diabetic medications.
Interventions
Partial weight bearing (25% weight support) during the moderate intensity aerobic exercise training on the antigravity treadmill
Full weight bearing (100% weight loading, 0% weight support) during moderate intensity aerobic exercise training on the antigravity treadmill.
Participants in the control group (group C) received regular oral anti-diabetic medications.
Eligibility Criteria
You may qualify if:
- Type 2 diabetes mellitus patients with 0.6\< ankle brachial index ≤ 0.9, treated only with oral hypoglycemic medications (Biguanide or Sulfonylureas + Biguanide), oral anti-diabetic drugs combination, with stable pharmacological treatment for at least 3 months before the study.
- Cognitively competent patients, able to walk independently with or without walking aids, assuming a Sedentary lifestyle (less than 30 minutes daily activity) during the last 6 months.
- Type 2 diabetes mellitus for more than 10 years, with glycosylated hemoglobin (HbA1c% %) level more than 7%, and fasting glucose level more than 7.0 mmol/L.
- Age range from 60 to 70 years, with normal/ accepted nutritional status (Mini Nutritional Assessment score more than 11).
You may not qualify if:
- Patients with Type 1 diabetes, younger than 60 or older than 70 years.
- Participation in any previous training program or diet regimen within the last 6 months.
- Patients with disturbed nutritional status (Mini Nutritional Assessment score less than 11).
- Serious musculoskeletal or cardiopulmonary disorders that can affect patient safety or the study results.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Umm Al-Qura University
Mecca, Saudi Arabia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
ASHRAF AM ABDELAAL, Ph.D.
Associate Professor
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 7, 2025
First Posted
May 15, 2025
Study Start
August 1, 2024
Primary Completion
March 1, 2025
Study Completion
May 1, 2025
Last Updated
May 15, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share
For privacy reasons, data can not be exposed until results' publication. Data summary will be confidentially provided upon request under limited situations.